美股市場個股詳情
TCDAQ TRICIDA INC
- 0.000010
- 0.0000000.00%
延時15分鐘行情收盤價 08/13 16:00 (美東)
580.28總市值0.00市盈率TTM
0.000000最高價0.000000最低價0股成交量0.000000今開0.000010昨收0.00成交額0.00%換手率0.00市盈率(靜)5802.83萬總股本0.00001052周最高0.00市淨率335.93流通值0.00001052周最低--股息TTM3359.29萬流通股44.300000歷史最高--股息率TTM0.00%振幅0.000010歷史最低--平均價1股每手
關於TRICIDA INC公司
Tricida Inc是一家制藥公司。 它專注於其候選藥物veverimer（TRC101）的開發和商業化，veverimer（TRC101）是一種非吸收性，口服給藥的聚合物，旨在通過結合和去除胃腸道或胃腸道中的酸來治療代謝性酸中毒。 關注的主要領域是通過代謝性酸中毒的治療來減緩慢性腎臟疾病的進展。
公司介紹
董事高管
- 姓名
- 職務
- 年薪
- Dr. Gerrit Klaerner, PhD.
- Director, President and Chief Executive Officer
- --
- Robert McKague
- Executive Vice President, General Counsel and Chief Compliance Officer
- --
- Geoffrey M. Parker
- Chief Operating Officer, Chief Financial Officer and Executive Vice President
- --
- Annie Yoshiyama
- Vice President, Finance and Chief Accounting Officer
- --
- Dr. Dawn Parsell
- Executive Vice President, Clinical Development
- --
- Dr. Klaus Veitinger, M.D.,PhD
- Chairman of the Board
- --
- Sandra I Coufal
- Independent Director
- --
- Kathryn E. Falberg
- Independent Director
- --
- Dr. Robert J. Alpern,M.D.
- Independent Director
- --
- Dr. David P. Bonita, M.D.
- Independent Director
- --
- Dr. David Hirsch, M.D.,PhD
- Independent Director
- --
- Thomas G. FitzGerald
- Independent Director
- --
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據